{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:20:18Z","timestamp":1791422418114,"version":"4.3.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,8,18]],"date-time":"2008-08-18T00:00:00Z","timestamp":1219017600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Human herpesvirus 8 (HHV-8), cytomegalovirus (CMV) and Epstein-Barr virus (EBV) are prevalent in Africa, but less common elsewhere and the modes of transmission are still subject to debate. Generally, they rarely cause disease in the immunocompetent host but are highly oncogenic when associated with immunosuppression. Although the high prevalence of HHV-8, CMV and EBV has been well documented in Africa, such data are sparse from Ghana.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Serum samples from 3275 HIV-seronegative healthy blood donors and 250 HIV-AIDS patients were tested for antibodies specific for HHV-8, CMV and EBV by IgG ELISA assays. Differences in seropositivity rates by gender and age were evaluated using the Chi-square test with Yates correction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 3275 HIV-seronegative healthy blood donors tested, 2573 (78.6%) were males and 702 (21.4%) were females, with ages ranging from 18 to 65 years (median 32.6; mean 31.2; mode 30). Of the 250 HIV-AIDS patients tested, 140 (56%) were males and 110 (44%) were females, with ages ranging from 17 to 64 years (median 30.8; mean 30.3; mode 28). Among the HIV-seronegative healthy blood donors, overall seroprevalence of HHV-8, CMV and EBV was 23.7%, 77.6% and 20.0%, respectively. Among the HIV-AIDS patients, overall seroprevalence of HHV-8, CMV and EBV was 65.6%, 59.2% and 87.2%, respectively. The seroprevalence of HHV-8 (p &lt; 0.005) and EBV (p &lt; 0.001) was statistically significantly higher in HIV-AIDS patients compared to HIV-seronegative healthy blood donors. There was no statistically significant difference (p = 0.24) between CMV seroprevalence in HIV-AIDS patients and HIV-seronegative healthy blood donors. Age and gender were not independent determinants (p &gt; 0.05) for all three infections among HIV-seronegative healthy blood donors and HIV-AIDS patients in Ghana.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The results presented herein indicate that HHV-8, CMV and EBV infections are hyperendemic in both HIV-seronegative and HIV-seropositive Ghanaians, and suggest primarily a horizontal route of transmission of these three viral infections in Ghana.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-8-111","type":"journal-article","created":{"date-parts":[[2008,8,19]],"date-time":"2008-08-19T06:13:37Z","timestamp":1219126417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa"],"prefix":"10.1186","volume":"8","author":[{"given":"Andrew A","family":"Adjei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry B","family":"Armah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foster","family":"Gbagbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Boamah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Adu-Gyamfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Asare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,8,18]]},"reference":[{"issue":"8","key":"702_CR1","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nm0896-925","volume":"2","author":"SJ Gao","year":"1996","unstructured":"Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, Moore PS: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med. 1996, 2 (8): 925-928. 10.1038\/nm0896-925.","journal-title":"Nat Med"},{"issue":"5","key":"702_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/jnci\/90.5.395","volume":"90","author":"D Whitby","year":"1998","unstructured":"Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G: Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst. 1998, 90 (5): 395-397. 10.1093\/jnci\/90.5.395.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"702_CR3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/sj.bjc.6690782","volume":"81","author":"D Ablashi","year":"1999","unstructured":"Ablashi D, Chatlynne L, Cooper H, Thomas D, Yadav M, Norhanom AW, Chandana AK, Churdboonchart V, Kulpradist SA, Patnaik M, Liegmann K, Masood R, Reitz M, Cleghorn F, Manns A, Levine PH, Rabkin C, Biggar R, Jensen F, Gill P, Jack N, Edwards J, Whitman J, Boshoff C: Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer. 1999, 81 (5): 893-897. 10.1038\/sj.bjc.6690782.","journal-title":"Br J Cancer"},{"issue":"2","key":"702_CR4","first-page":"50","volume":"11","author":"L Sarmati","year":"2004","unstructured":"Sarmati L: HHV-8 infection in African children. Herpes. 2004, 11 (2): 50-53.","journal-title":"Herpes"},{"issue":"5192","key":"702_CR5","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1126\/science.7997879","volume":"266","author":"Y Chang","year":"1994","unstructured":"Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994, 266 (5192): 1865-1869. 10.1126\/science.7997879.","journal-title":"Science"},{"issue":"4","key":"702_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/infdis\/171.4.1002","volume":"171","author":"LJ Zhang","year":"1995","unstructured":"Zhang LJ, Hanff P, Rutherford C, Churchill WH, Crumpacker CS: Detection of human cytomegalovirus DNA, RNA, and antibody in normal donor blood. J Infect Dis. 1995, 171 (4): 1002-1006.","journal-title":"J Infect Dis"},{"issue":"1","key":"702_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.0042-9007.2004.00388.x","volume":"86","author":"M Hecker","year":"2004","unstructured":"Hecker M, Qiu D, Marquardt K, Bein G, Hackstein H: Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang. 2004, 86 (1): 41-44. 10.1111\/j.0042-9007.2004.00388.x.","journal-title":"Vox Sang"},{"issue":"12","key":"702_CR8","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1002\/jmv.20748","volume":"78","author":"M Nishiwaki","year":"2006","unstructured":"Nishiwaki M, Fujimuro M, Teishikata Y, Inoue H, Sasajima H, Nakaso K, Nakashima K, Sadanari H, Yamamoto T, Fujiwara Y, Ogawa N, Yokosawa H: Epidemiology of Epstein-Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay. J Med Virol. 2006, 78 (12): 1635-1642. 10.1002\/jmv.20748.","journal-title":"J Med Virol"},{"issue":"1","key":"702_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/ijc.2910350107","volume":"35","author":"QY Yao","year":"1985","unstructured":"Yao QY, Rickinson AB, Epstein MA: A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer. 1985, 35 (1): 35-42. 10.1002\/ijc.2910350107.","journal-title":"Int J Cancer"},{"issue":"3","key":"702_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ijc.2910220304","volume":"22","author":"RJ Biggar","year":"1978","unstructured":"Biggar RJ, Henle W, Fleisher G, Bocker J, Lennette ET, Henle G: Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer. 1978, 22 (3): 239-243. 10.1002\/ijc.2910220304.","journal-title":"Int J Cancer"},{"issue":"1","key":"702_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bjc.6600745","volume":"88","author":"M Dedicoat","year":"2003","unstructured":"Dedicoat M, Newton R: Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer. 2003, 88 (1): 1-3. 10.1038\/sj.bjc.6600745.","journal-title":"Br J Cancer"},{"key":"702_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1471-2458-6-159","volume":"6","author":"EK Wiredu","year":"2006","unstructured":"Wiredu EK, Armah HB: Cancer mortality patterns in Ghana: a 10-year review of autopsies and hospital mortality. BMC Public Health. 2006, 6: 159-10.1186\/1471-2458-6-159.","journal-title":"BMC Public Health"},{"issue":"5","key":"702_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s100960100517","volume":"20","author":"SV Nuvor","year":"2001","unstructured":"Nuvor SV, Katano H, Ampofo WK, Barnor JS, Sata T: Higher prevalence of antibodies to human herpesvirus 8 in HIV-infected individuals than in the general population in Ghana, West Africa. Eur J Clin Microbiol Infect Dis. 2001, 20 (5): 362-364. 10.1007\/s100960100517.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"702_CR14","first-page":"99","volume":"40","author":"A Adjei","year":"2006","unstructured":"Adjei A, Armah H, Narter-Olaga E: Seroprevalence of cytomegalovirus among some voluntary blood donors at the 37 military hospital, accra, ghana. Ghana Med J. 2006, 40 (3): 99-104.","journal-title":"Ghana Med J"},{"issue":"5","key":"702_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1365-3083.2005.01589.x","volume":"61","author":"N Rasti","year":"2005","unstructured":"Rasti N, Falk KI, Donati D, Gyan BA, Goka BQ, Troye-Blomberg M, Akanmori BD, Kurtzhals JA, Dodoo D, Consolini R, Linde A, Wahlgren M, Bejarano MT: Circulating epstein-barr virus in children living in malaria-endemic areas. Scand J Immunol. 2005, 61 (5): 461-465. 10.1111\/j.1365-3083.2005.01589.x.","journal-title":"Scand J Immunol"},{"issue":"2","key":"702_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<189::AID-IJC4>3.0.CO;2-E","volume":"81","author":"A Gessain","year":"1999","unstructured":"Gessain A, Mauclere P, van Beveren M, Plancoulaine S, Ayouba A, Essame-Oyono JL, Martin PM, de The G: Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer. 1999, 81 (2): 189-192. 10.1002\/(SICI)1097-0215(19990412)81:2<189::AID-IJC4>3.0.CO;2-E.","journal-title":"Int J Cancer"},{"key":"702_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1743-422X-2-78","volume":"2","author":"DC Edelman","year":"2005","unstructured":"Edelman DC: Human herpesvirus 8--a novel human pathogen. Virol J. 2005, 2: 78-10.1186\/1743-422X-2-78.","journal-title":"Virol J"},{"issue":"11","key":"702_CR18","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1086\/374973","volume":"187","author":"SM Mbulaiteye","year":"2003","unstructured":"Mbulaiteye SM, Pfeiffer RM, Whitby D, Brubaker GR, Shao J, Biggar RJ: Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis. 2003, 187 (11): 1780-1785. 10.1086\/374973.","journal-title":"J Infect Dis"},{"issue":"3","key":"702_CR19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.micinf.2003.11.013","volume":"6","author":"P De Paoli","year":"2004","unstructured":"De Paoli P: Human herpesvirus 8: an update. Microbes Infect. 2004, 6 (3): 328-335. 10.1016\/j.micinf.2003.11.013.","journal-title":"Microbes Infect"},{"issue":"9235","key":"702_CR20","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/S0140-6736(00)02729-X","volume":"356","author":"S Plancoulaine","year":"2000","unstructured":"Plancoulaine S, Abel L, van Beveren M, Tregouet DA, Joubert M, Tortevoye P, de The G, Gessain A: Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet. 2000, 356 (9235): 1062-1065. 10.1016\/S0140-6736(00)02729-X.","journal-title":"Lancet"},{"issue":"6","key":"702_CR21","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1086\/423326","volume":"190","author":"M Dedicoat","year":"2004","unstructured":"Dedicoat M, Newton R, Alkharsah KR, Sheldon J, Szabados I, Ndlovu B, Page T, Casabonne D, Gilks CF, Cassol SA, Whitby D, Schulz TF: Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis. 2004, 190 (6): 1068-1075. 10.1086\/423326.","journal-title":"J Infect Dis"},{"issue":"18","key":"702_CR22","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1097\/00002030-200212060-00014","volume":"16","author":"MA Eltom","year":"2002","unstructured":"Eltom MA, Mbulaiteye SM, Dada AJ, Whitby D, Biggar RJ: Transmission of human herpesvirus 8 by sexual activity among adults in Lagos, Nigeria. Aids. 2002, 16 (18): 2473-2478. 10.1097\/00002030-200212060-00014.","journal-title":"Aids"},{"issue":"3","key":"702_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/jmv.20200","volume":"74","author":"A Volpi","year":"2004","unstructured":"Volpi A, Sarmati L, Suligoi B, Montano M, Rezza G, Andreoni M: Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon. J Med Virol. 2004, 74 (3): 467-472. 10.1002\/jmv.20200.","journal-title":"J Med Virol"},{"issue":"3","key":"702_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/00007435-200003000-00008","volume":"27","author":"G Rezza","year":"2000","unstructured":"Rezza G, Tchangmena OB, Andreoni M, Bugarini R, Toma L, Bakary DK, Glikoutou M, Sarmati L, Monini P, Pezzotti P, Ensoli B: Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. Sex Transm Dis. 2000, 27 (3): 159-164. 10.1097\/00007435-200003000-00008.","journal-title":"Sex Transm Dis"},{"issue":"12","key":"702_CR25","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1097\/00002030-200308150-00001","volume":"17","author":"NH Dukers","year":"2003","unstructured":"Dukers NH, Rezza G: Human herpesvirus 8 epidemiology: what we do and do not know. Aids. 2003, 17 (12): 1717-1730. 10.1097\/00002030-200308150-00001.","journal-title":"Aids"},{"issue":"1","key":"702_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/rmv.341","volume":"12","author":"L Corey","year":"2002","unstructured":"Corey L, Brodie S, Huang ML, Koelle DM, Wald A: HHV-8 infection: a model for reactivation and transmission. Rev Med Virol. 2002, 12 (1): 47-63. 10.1002\/rmv.341.","journal-title":"Rev Med Virol"},{"issue":"6","key":"702_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1590\/S0036-46652002000600003","volume":"44","author":"RB Freitas","year":"2002","unstructured":"Freitas RB, Freitas MR, Linhares AC: Prevalence of human herpesvirus 8 antibodies in the population of Belem, Para, Brazil. Rev Inst Med Trop Sao Paulo. 2002, 44 (6): 309-313.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"5","key":"702_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/jmv.20593","volume":"78","author":"E Collenberg","year":"2006","unstructured":"Collenberg E, Ouedraogo T, Ganame J, Fickenscher H, Kynast-Wolf G, Becher H, Kouyate B, Krausslich HG, Sangare L, Tebit DM: Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis. J Med Virol. 2006, 78 (5): 683-692. 10.1002\/jmv.20593.","journal-title":"J Med Virol"},{"issue":"8-9","key":"702_CR29","first-page":"512","volume":"78","author":"J Gargouri","year":"2000","unstructured":"Gargouri J, Elleuch H, Karray H, Rekik H, Hammami A: [Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion)]. Tunis Med. 2000, 78 (8-9): 512-517.","journal-title":"Tunis Med"},{"issue":"4","key":"702_CR30","first-page":"348","volume":"20","author":"A Kothari","year":"2002","unstructured":"Kothari A, Ramachandran VG, Gupta P, Singh B, Talwar V: Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India. J Health Popul Nutr. 2002, 20 (4): 348-351.","journal-title":"J Health Popul Nutr"},{"issue":"13","key":"702_CR31","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1056\/NEJMoa055009","volume":"355","author":"W Hladik","year":"2006","unstructured":"Hladik W, Dollard SC, Mermin J, Fowlkes AL, Downing R, Amin MM, Banage F, Nzaro E, Kataaha P, Dondero TJ, Pellett PE, Lackritz EM: Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med. 2006, 355 (13): 1331-1338. 10.1056\/NEJMoa055009.","journal-title":"N Engl J Med"},{"issue":"11","key":"702_CR32","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1111\/j.1537-2995.2007.01494.x","volume":"47","author":"WL Drew","year":"2007","unstructured":"Drew WL, Roback JD: Prevention of transfusion-transmitted cytomegalovirus: reactivation of the debate?. Transfusion. 2007, 47 (11): 1955-1958. 10.1111\/j.1537-2995.2007.01494.x.","journal-title":"Transfusion"},{"issue":"16","key":"702_CR33","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1056\/NEJM198604173141602","volume":"314","author":"RA Bowden","year":"1986","unstructured":"Bowden RA, Sayers M, Flournoy N, Newton B, Banaji M, Thomas ED, Meyers JD: Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med. 1986, 314 (16): 1006-1010.","journal-title":"N Engl J Med"},{"issue":"3","key":"702_CR34","first-page":"227","volume":"7","author":"WJ Miller","year":"1991","unstructured":"Miller WJ, McCullough J, Balfour HH, Haake RJ, Ramsay NK, Goldman A, Bowman R, Kersey J: Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening. Bone Marrow Transplant. 1991, 7 (3): 227-234.","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"702_CR35","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1182\/blood-2002-10-3143","volume":"101","author":"WG Nichols","year":"2003","unstructured":"Nichols WG, Price TH, Gooley T, Corey L, Boeckh M: Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood. 2003, 101 (10): 4195-4200. 10.1182\/blood-2002-10-3143.","journal-title":"Blood"},{"issue":"9","key":"702_CR36","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1182\/blood.V86.9.3598.bloodjournal8693598","volume":"86","author":"RA Bowden","year":"1995","unstructured":"Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L, McCullough J, Miller W: A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood. 1995, 86 (9): 3598-3603.","journal-title":"Blood"},{"issue":"3","key":"702_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.tmrv.2005.02.002","volume":"19","author":"EC Vamvakas","year":"2005","unstructured":"Vamvakas EC: Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis. Transfus Med Rev. 2005, 19 (3): 181-199. 10.1016\/j.tmrv.2005.02.002.","journal-title":"Transfus Med Rev"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-8-111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-8-111\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-8-111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-8-111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T09:35:17Z","timestamp":1630488917000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-8-111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,18]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["702"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-8-111","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,18]]},"assertion":[{"value":"2 April 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"111"}}